NVO's Levemir Label Expanded - Yahoo Finance

Novo Nordisk (NVO) recently announced that the U.S. Food and Drug Administration (:FDA) expanded the label of its diabetes drug, Levemir (insulin detemir [rDNA origin] injection). Levemir, a long-acting insulin analogue, received approval for ...

NVO's Levemir Label Expanded - Analyst Blog - NASDAQ

Novo Nordisk ( NVO) recently announced that the U.S. Food and Drug Administration (FDA) expanded the label of its diabetes drug, Levemir (insulin detemir [rDNA origin] injection). Levemir, a long-acting insulin analogue, received approval for type I ...

Levemir Expands Pediatric Indication - Monthly Prescribing Reference

Novo Nordisk announced that the FDA has approved Levemir (insulin detemir [rDNA origin] injection) for use in children ages two to five years with type 1 diabetes. This expansion now makes Levemir the first and only basal insulin analog available for use ...

FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes - Phramalive.com

PRINCETON, N.J., May 22, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir® (insulin detemir [rDNA origin] injection) for use in children ages two to ...

Novo Nordisk diabetes drug gets broader approval - Yahoo Finance

NEW YORK (AP) -- Danish drugmaker Novo Nordisk A/S said Tuesday that the Food and Drug Administration granted an additional marketing approval for its diabetes drug Levemir. Novo Nordisk says Levemir is now approved for use in children with type ...

New Market Study Published: Levemir (Type 2 Diabetes) - Analysis and Forecasts to 2020 - SBWire

Williamstown, MA -- (SBWIRE) -- 05/10/2012 -- GlobalData's pharmaceuticals report, "Levemir (Type 2 Diabetes) - Analysis and Forecasts to 2020" provides Levemir sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of ...

FDA approves younger children's use of Novo's diabetes drug Levemir - SmartBrief

Novo Nordisk's insulin analog Levemir was approved by the FDA for 2- to 5-year-olds with type 1 diabetes. The agency based the expanded approval on a study that found the drug was as effective as neutral protamine Hagedorn insulin based on mean A1C values ...

Canada Pharmacies Applaud New Developments in Artificial Pancreas for Type 1 Diabetics - PR-USA.net

Big Mountain Drugs have different types of insulin at very low prices. The products available are Levemir, Novolin, Lantus Humulin, Humolog and Apidra. They carry a very wide range of diabetic medication and products that includes a large number of ...

Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 - new market research report - Transworld News

The annual cost of type 2 diabetes therapy was driven by the uptake of newly approved drugs, such as Actos (pioglitazone) and Avandia (rosiglitazone) until 2006 and the launch of new therapies, such as Levemir (insulin detemir), Byetta (exenatide), Januvia ...